NCT02827357View on ClinicalTrials.gov

Responses to Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 Mutation

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Lung Cancer
Interventions
OTHER

No specific intervention

Clinical, drug and data collection : characteristics of patients (age, sex and histology), non HER 2-directed treatments including response and duration of response

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT02827357 - Responses to Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 Mutation | Biotech Hunter | Biotech Hunter